Literature DB >> 21871249

Treating Clostridium difficile infection with fecal microbiota transplantation.

Johan S Bakken1, Thomas Borody, Lawrence J Brandt, Joel V Brill, Daniel C Demarco, Marc Alaric Franzos, Colleen Kelly, Alexander Khoruts, Thomas Louie, Lawrence P Martinelli, Thomas A Moore, George Russell, Christina Surawicz.   

Abstract

Clostridium difficile infection is increasing in incidence, severity, and mortality. Treatment options are limited and appear to be losing efficacy. Recurrent disease is especially challenging; extended treatment with oral vancomycin is becoming increasingly common but is expensive. Fecal microbiota transplantation is safe, inexpensive, and effective; according to case and small series reports, about 90% of patients are cured. We discuss the rationale, methods, and use of fecal microbiota transplantation.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21871249      PMCID: PMC3223289          DOI: 10.1016/j.cgh.2011.08.014

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  31 in total

1.  Probiotics for recurrent Clostridium difficile disease.

Authors:  Steven J Lawrence; Joshua R Korzenik; Linda M Mundy
Journal:  J Med Microbiol       Date:  2005-09       Impact factor: 2.472

2.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Authors:  Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

Review 3.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

Review 4.  The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review.

Authors:  John O'Horo; Nasia Safdar
Journal:  Int J Infect Dis       Date:  2009-01-30       Impact factor: 3.623

5.  Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

Authors:  Lynne V McFarland; Jill E Clarridge; Henry W Beneda; Gregory J Raugi
Journal:  Clin Infect Dis       Date:  2007-09-26       Impact factor: 9.079

Review 6.  Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies.

Authors:  Lynne V McFarland
Journal:  Curr Opin Gastroenterol       Date:  2009-01       Impact factor: 3.287

7.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Authors:  Rocco Ricciardi; David A Rothenberger; Robert D Madoff; Nancy N Baxter
Journal:  Arch Surg       Date:  2007-07

8.  Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series.

Authors:  A A MacConnachie; R Fox; D R Kennedy; R A Seaton
Journal:  QJM       Date:  2009-09-02

Review 9.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

10.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.

Authors:  L Clifford McDonald; Maria Owings; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

View more
  307 in total

1.  Fecal transplantation for the treatment of Clostridium difficile infection.

Authors:  Lawrence J Brandt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

2.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2012

Review 3.  Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology.

Authors:  Patricia Ojeda; Alexandria Bobe; Kyle Dolan; Vanessa Leone; Kristina Martinez
Journal:  J Nutr Biochem       Date:  2015-08-20       Impact factor: 6.048

Review 4.  Human microbiome: From the bathroom to the bedside.

Authors:  Stephen Malnick; Ehud Melzer
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

Review 5.  Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.

Authors:  L Patrick Schenck; Paul L Beck; Justin A MacDonald
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 6.  Recurrent Clostridium difficile infection and the microbiome.

Authors:  Rowena Almeida; Teklu Gerbaba; Elaine O Petrof
Journal:  J Gastroenterol       Date:  2015-07-08       Impact factor: 7.527

Review 7.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

8.  Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.

Authors:  Andrada Seicean; Anca Moldovan-Pop; Radu Seicean
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 9.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

Review 10.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.